EN
抗体药类似物
Research Grade Azintuxizumab
All
  • CatalogTD-HV217026
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsABBV-383,PR-1471272,ABBV-838,CAS:1826819-57-1
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Azintuxizumab


Catalog No. TD-HV217026
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG1-kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target SLAMF7, CRACC, Protein 19A, SLAM family member 7, CD2-like receptor-activating cytotoxic cells, Membrane protein FOAP-12, CD319, Novel Ly9, CD2 subset 1, CS1
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession Q9NQ25
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names ABBV-383,PR-1471272,ABBV-838,CAS:1826819-57-1
Background Azintuxizumab is an anti-SLAMF7 human IgG4κ monoclonal antibody. Azintuxizumab can be used in the synthesis of antibody-drug conjugate (ADC), Azintuxizumab vedotin.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HV217026_1.jpg
Bioactivity
 
SEC-HPLC detection for Research Grade Azintuxizumab.